Monitoring the Switch from
tOPV to bOPV
Guidelines for Developing
National Monitoring Plans
13 March 2016
Please note: This document is an update of a version released in August 2015.
The main changes in the March 2016 version concern the new steps in the ‘Prepare’ phase and the
new tools and forms provided in the Annexes.
1
Table of Contents
Acronyms ...................................................................................................................................................................3
Introduction ...............................................................................................................................................................4
What are the general principles of this document?...............................................................................................6
Recap – Monitoring on a page ...............................................................................................................................7
1.
Plan .....................................................................................................................................................................8
1.1. Develop a Monitoring Structure .................................................................................................................8
1.2. Timeline of Activities ............................................................................................................................... 10
1.3. Switch Validation Indicators .................................................................................................................... 11
1.4. Identify Human and Financial Resources ................................................................................................ 11
2.
Prepare ............................................................................................................................................................ 12
2.1. Develop data collection tools .................................................................................................................. 12
2.2. Develop training materials ...................................................................................................................... 14
2.3. Identify Facilities for Monitoring ............................................................................................................. 14
2.4. Develop Micro-Plans................................................................................................................................ 16
2.5. Develop Contingency Plans ..................................................................................................................... 16
2.6. Recruit supervisors & monitors ............................................................................................................... 16
2.7. Train supervisors & monitors .................................................................................................................. 18
2.8. Pre-position supervisors & monitors ....................................................................................................... 18
3.
Validate ........................................................................................................................................................... 19
3.1. Monitors visit cold chain stores and service delivery points................................................................... 19
3.2. Data Reported and Aggregated ............................................................................................................... 21
3.3. Develop validation report........................................................................................................................ 21
4.
Follow-Up ........................................................................................................................................................ 22
4.1. tOPV Withdrawal ..................................................................................................................................... 22
4.2. Problems Identified during Monitoring ................................................................................................... 23
Annexes ................................................................................................................................................................... 24
Annex A: Monitoring tOPV Disposal .................................................................................................................... 24
Annex B: Categorizing Risk of tOPV Use .............................................................................................................. 26
Risk of tOPV Stored and Used During the Switch ............................................................................................ 26
Annex C: Example Forms ..................................................................................................................................... 27
Form 1: Sample Independent Monitoring Data Collection Tool .................................................................... 27
Form 2: Sample National Switch Validation Data Aggregation Tool .............................................................. 28
Form 3: National Validation Report: Switch from tOPV to bOPV ................................................................... 30
Instruction Sheet: National Switch Data Aggregation Form & Validation Report........................................... 31
tOPV Disposal Form – Supervisors .................................................................................................................. 36
2
Acronyms
AFP
bOPV
DPT3
DSO
EPI
IPV
NGO
NIP
OPV3
tOPV
UNICEF
WHO
Acute Flaccid Paralysis
Bivalent Oral Polio Vaccine
Third dose of diphtheria-pertussis-tetanus vaccine
District Surveillance Officer
Expanded Programme on Immunization
Inactivated Polio Vaccine
Non-governmental Organization
National Immunization Program. Sometimes used interchangeably with EPI
Third dose of Oral Polio Vaccine
Trivalent Oral Polio Vaccine
United Nations Children’s Fund
World Health Organization
26
Introduction
The World Health Assembly has endorsed the SAGE recommendation for a synchronized switch from tOPV to
bOPV in all 156 OPV using countries and regions during a two week period in April 2016 (April 17-May 1, 2016, if
endorsed by SAGE in October 2015). A key component of a successful switch involves effective monitoring of
health facilities after the national switch date in all countries to ensure that tOPV is no longer available for
administration. Ensuring that tOPV is no longer being administered or in the cold chain is a country
responsibility. This document outlines for countries GPEI’s recommended monitoring strategy for withdrawal
of all tOPV from cold chain storage points. The document provides step by step guidance on planning,
preparing, collecting and reporting data, and corrective actions for monitoring the switch (Box 1).
The key objectives of the monitoring strategy are to:
1) Conduct site visits at all cold chain stores from the national to the district levels (where the largest
quantities of tOPV will generally be stored at the time of the switch), as well as selected service
delivery points (health facilities), in order to verify removal of these stocks from the cold chain;
2) Take corrective action to remove tOPV stocks from the cold chain if found and mark these stocks
for disposal;
3) Assess performance of the switch; and
4) Assess the status of bOPV and IPV distribution at monitored facilities.
Monitoring the withdrawal of tOPV from cold chain stores and service points is a separate process
from the certification of containment or destruction of poliovirus at laboratories and vaccine
production facilities.
The destruction and containment of poliovirus at laboratories and vaccine production facilities described in the
Global Action Plan to Minimize Poliovirus Facility-associated Risk after Type-specific Eradication of Wild
Polioviruses and Sequential Cessation of Routine OPV Use (known as GAP-III) is a separate process from the
withdrawal of tOPV. As a result, the requirements for the certification of the containment or destruction of
poliovirus at laboratories and vaccine production facilities do not apply to the monitoring of tOPV withdrawal.
However, switch monitoring activities may occur simultaneously with efforts to certify containment or
destruction of poliovirus at laboratories and vaccine production facilities and may involve the same key staff.
26
BOX 1: MONITORING OVERVIEW
Objectives of Switch Monitoring
 Ensure and validate withdrawal of tOPV (primary)
 Assess introduction of bOPV (secondary)
 Assess distribution of IPV (secondary)
Independent Monitoring Period: completed within 2 weeks of the national switch date in April 2016
Planning and preparing for the monitoring:
a. Convene a committee (e.g., National Switch Validation Committee) that is
independent from switch implementation activities to provide monitoring oversight
and validate switch
b. Develop TORs for the Switch Monitors
c. Adapt data collection tools and reporting mechanism for the independent
monitoring
d. Hire and train the Switch Monitors
Monitoring site selection:
a. Independently monitor ALL facilities down to the district level
b. Independently monitor a SAMPLE of the service points (health care facilities) using a
risk-based, purposive strategy described in Section 3.
Corrective action: All monitoring efforts should be linked with corrective action (in other words,
removal of tOPV from the cold chain).
Reporting: Monitors should report data daily to the Monitoring Supervisor / Coordinator, who
aggregates the data and submits to the National Switch Validation Committee. The National Switch
Validation Committee should report the validation results to the World Health Organization within
two weeks of the national switch date.
Additional monitoring: Supportive supervision visits can supplement independent monitoring of
health facilities to provide additional verification of the adequate withdrawal of tOPV from the cold
chain. These additional monitoring activities for tOPV withdrawal should be completed as soon as
possible, while tOPV disposal should occur within 3 months of the switch; these activities can be
conducted through regular activities of national immunization programs.
NOTE: The data collected through supportive supervision visits are not part of the validation
process that should occur within 2 weeks of the national switch date.
26
What are the general principles of this document?
What is included in this document?
This document provides a framework for countries to consider when developing and implementing their plans
for monitoring the switch. This document focuses on the minimal recommendations for monitoring the
withdrawal of tOPV, the introduction of bOPV, and the distribution of IPV (health facilities should have both
bOPV and IPV stocks on the National Switch Day) during the two weeks following the switch. Countries can go
beyond these recommendations by adding more activities and indicators that are specific to their National
Immunization Program goals.
This document can also be adapted to a field guide for training based on local needs.
Who is the target audience?
Members of the National Switch Validation Committee, country policy makers, program managers, logisticians,
and consultants who are involved in the planning, preparation, and implementation of the switch are the
primary target audience. This document explains how to establish a system that will provide timely and useful
data for validating the switch.
26
Recap – Monitoring on a page
The table below summarizes the key activities of the monitoring activities.
By September 2015
Independent Monitoring Period
Plan




Develop monitoring structure
Determine timeline of activities
Develop indicators for switch validation
Identify human and financial resources needed
October 2015 – February 2016
Prepare
National
Switch Day
 Adapt Independent Monitoring data collection and aggregation tools
 Develop training materials
 Create roster of facilities to monitor
 Recruit supervisors and monitors
 Train supervisors and monitors
 Develop micro-plans
 Develop contingency plans
A day chosen during the last 2 weeks of April 2016
(Date to be finalized by SAGE in October 2015)
April 2016 - During the two weeks after the National Switch Day
Follow-up
Monitoring
Period
Validate
Follow-Up
 Monitors visit cold chain stores and service delivery points
 Data reported and aggregated
 Develop validation report
2-3 months ongoing after the switch
 Additional monitoring of tOPV withdrawal as needed
 Correcting identified problems
 Monitoring tOPV disposal as desired
26
1. Plan
Plan




Prepare
Validate
Follow-Up
Develop monitoring structure
Determine timeline of activities
Develop indicators for switch validation
Identify human and financial resources needed
1.1. Develop a Monitoring Structure
Identify the staff that will be included in monitoring activities at each level of the health system. Review the
descriptions of each of the key players for the monitoring structure below and determine which National
Immunization Program staff will be used, if other health workers will be needed, and if partner organizations
should also be included in the monitoring activities.
National Switch Validation Committee: A body independent from switch implementation activities that is
authorized by the government to validate the switch and certify that tOPV has been withdrawn from the cold
chain. A country’s National Certification Committee could be used for this purpose if it is active, or members of
the National Switch Validation Committee could be drawn from the National Certification Committee or other
authorities not part of the Switch Management Committee.
Monitoring Coordinators or Supervisors: Staff independent from switch implementation activities that are
responsible for managing monitors and collecting and responding to data. Coordinators and supervisors:
 Identify cold chain stores to be visited
 Select service delivery points to be visited
 Develop and provide training material
 Facilitate logistics for the training and transportation of independent monitors.
 Facilitate reproduction and distribution of data collection tools and guidelines for monitors.
 Develop a micro-plan for independent monitors and their supervisors. The plan will be accompanied by
a map and will assign each monitor to areas to be monitored each day
WHO or UNICEF Country Offices may provide coordinators to manage switch monitoring. In larger countries,
separate switch monitoring supervisors may be needed for individual states, provinces, or districts. However,
26
such state and local switch monitoring supervisors should ultimately report to a national switch coordinator who
will work with the National Switch Validation Committee.
Independent Monitors: Persons who will assess the cold chain storage sites and service points with a data
collection tool. These persons should not be directly involved with the organizations implementing the switch
itself because their independence from those organizations is important for allowing them to provide honest
assessments.
Switch Management Committee (not part of monitoring structure):
 Plans, manages, and oversees all activities relating to the switch, including identification of the sites to
be monitored at the regional and national levels
 Receives updates on monitoring activities and findings
 Takes appropriate programmatic action in case large amounts of tOPV are found at cold chain stores or
service points and/or IPV and bOPV is not available.
Working groups used during SIAs could potentially serve as regional or national Switch Management
Committees.
Box 2: What does “independent” mean?
For monitoring the switch, “independent” refers to the use of coordinators/supervisors and
monitors who are not directly involved with executing the switch and are therefore more
likely to provide unbiased assessments of the switch’s implementation. These individuals
may come from the health sector and may be employed by the government or come from
local NGOs or universities. However, if these individuals were directly involved with switch
execution or planning activities in a given region or district, they should not participate in
monitoring activities in these areas, but can participate in other regions or districts where
they have not been directly involved with executing the switch. Independent coordinators
and monitors may be from other countries, but it is not necessary to have international
monitors for switch validation.
Overall, individuals who can provide unbiased, credible assessments of how well the switch
has been performed are well suited to be being involved with switch monitoring.
26
1.2. Timeline of Activities
Determine the major activities to schedule for switch monitoring. The exact activities and their timing may vary
by country.
April 2016 Calendar
Sun
3
Mon
4
Tue
5
Wed
6
10
11
12
13
17
18
National
Switch Day
25
19
24
26
Thu
7
Fri
8
Sat
9
14
15
16
21
22 the cold
Stop use20
of tOPV and remove
tOPV from
chain. Begin use of bOPV and disposal of tOPV
27
28
29
23
30
Two-week window for monitoring cold chain
stores, collecting and reporting validation data
1
8
2
National
Validation Day
9
3
10
4
5
6
7
Complete disposal of tOPV as soon as possible, but no
11 3 months 12
13
14
later than
after National Switch
Day
Pre-Switch Activities:
 Identify monitors - 1-2 months before switch
 Notify monitors of switch activities - 1 month before switch
 Train monitors - 2-4 weeks before switch
 Develop monitoring plans for which cold chain stores or service points will be visited by each monitor 1-2 weeks before switch
 Distribute data collection tools to monitors - 1 week before switch
2 week Switch Validation Activities:
 Monitors collect information on switch performance during the 2 weeks after the National Switch Day
 Monitors withdraw tOPV if found at any site
 Monitors and their supervisors report information to the National Switch Validation Committee within 3
days of the assessment and no later than 2 weeks after the National Switch Day
 Data aggregated by National Switch Validation Committee and reported to the Switch Management
Committee. - Continuous process, but should ideally be completed within 2 weeks of the National
Switch Day
Post-Switch Activities:
 After validation, provide supportive supervision for 2-3 months to increase confidence that tOPV has
been fully withdrawn from all service points
 Dispose of all tOPV- As soon as possible, but no later than 3 months after the National Switch Day
26
1.3. Switch Validation Indicators
National Immunization Program and health sector staff, including the Switch Management Committee, will need
to determine the core indicators to validate that the switch has occurred at each level of the cold chain. The
following indicators should be considered the minimum needed for Switch validation, with the indicators related
to tOPV being the most important:
 The number and percent of cold chain stores and service points where tOPV is present
 Among cold chain stores and service points with tOPV, the number and percent of sites at which at least
one tOPV vial was found inside the cold chain
 Among cold chain stores and service points with tOPV, the number and percent of sites at which at least
one vial of tOPV was found outside the cold chain
 The number and percent of cold chain stores and service points with bOPV
 The number and percent of cold chain stores and service points with IPV
See Annex C for an example of a data collection form that can be used to collect the information needed for
these minimum indicators from cold chain stores and service points.
Additional indicators can be included if the National Immunization Program program is interested in collecting
other types of information. Data collection forms and the monitoring structure can be adapted to the needs of
the country National Immunization Program program and their current management structure.
1.4. Identify Human and Financial Resources
Based on the planned activities, identify the human resources that will be needed with any other resources such
as transportation, supplies, data reporting tools, etc. The budget tool that was provided to the National Switch
Management Committee can be used for estimations.
26
2. Prepare
Plan
Prepare







Validate
Follow-Up
Develop data collection and aggregation
tools
Develop training materials
Create roster of facilities to monitor
Develop micro-plans
Develop contingency plans
Recruit supervisors and monitors
Train supervisors and monitors
2.1. Develop data collection tools
Monitors will need to use data collection tools (for an example Form 1 in Annex C, see Note: The forms included in
this guide include the core indicators that are needed to validate the switch. Additional indicators can be included if switch
monitors
are
tasked
with
collecting
information
on
other
immunization
activities.
26
) in order to capture all of the information needed to validate the switch. Depending on the rigor of the
validation process, the forms can vary in length and depth. The forms should include enough questions to
capture the information needed for the minimum indicators for validating the switch.
The forms can also include instructions for what monitors should do if they find tOPV at a cold chain store or
service point. For some countries, SMS or other electronic mechanisms can be used to collect the information
needed for switch validation.
Collection tools can be a simple paper based form that compiles the required information to compute the
minimum indicators required (for an example see Annex C: Sample Independent Monitoring Data Collection
Tool, available in word and excel).
13
Table 1. Data fields collected by tools
Simple collection tool
 Facility type/name:
 Date of the visit
 Number of vials of tOPV found
 tOPV kept in or outside of the cold
chain:
o In the cold chain
o Outside of the cold chain
 bOPV present at the facility:
o Yes
o No
 IPV present at the facility:
o Yes
o No













14
Complete collection tool
Facility type/name:
o National (name)
o Regional (name)
o District (name)
o Service Point (name)
Date of the visit
Date of the switch on site
tOPV present at the facility:
o Yes
o No
Number of vials of tOPV found
tOPV kept in or outside of the cold chain:
o In the cold chain
o Outside of the cold chain
Plans for tOPV:
o Destroy it on-site
o Keep it out of the cold chain
o Transport it to a tOPV disposal site
o Wait for someone to pick up the tOPV
Reasons for not disposing or transferring the tOPV
o Unaware of need to dispose of or transfer
tOPV
o Did not receive clear guidelines
o Need additional assistance
o Did not have time yet to do it.
Destination for tOPV withdrawn
bOPV present at the facility:
o Yes
o No
Staff started to administer the bOPV or distribute
it for administration
o Yes
o No, but plan to start administering or
distributing the vaccine soon
o No, and have no plans to start
administering or distributing the vaccine
IPV present at the facility:
o Yes
o No
Staff started to administer the bOPV or distribute
it for administration
o Yes
o No, but plan to start administering or
distributing the vaccine soon
o No, and have no plans to start
administering or distributing the vaccine
2.2. Develop training materials
The training material should cover the following topics:
 Information about the switch
 Purpose of the monitoring activity, its objectives and the role of independent monitors
 Timeline of the independent monitoring
 Description of the behaviour and profile of an independent monitor and his/her interaction with health
workers
 Description of the tasks of the independent monitor
 Review of tools (forms) used: exercise and examples
 Addressing concerns, previous mistakes and handling misleading information
 Developing independent monitoring micro-plan and how to follow it
 Diplomacies for tOPV disposal activities.
Sample training module available at:
http://www.who.int/immunization/diseases/poliomyelitis/endgame_objective2/oral_polio_vaccine/monitoring
/en/
2.3. Identify Facilities for Monitoring
The goal here is to identify which facilities in the cold chain need to be visited for the efficient validation of tOPV
withdrawal and bOPV introduction. The recommended risk-based purposive (in other words, non-random)
sampling monitoring strategy is intended to rapidly identify the cold chain stores and service points possibly
holding the largest stocks of tOPV after the switch and facilitate immediate corrective action.
Steps:
1. Generate a line-list of cold chain stores that stock tOPV from the national to the district level (in other
words, all national, regional, and district cold chain stores) along with their last known tOPV stock levels
(if possible). Monitors should visit all of these stores.
2. Generate a line-list of the service points that can store tOPV in a working refrigerator or freezer for more
than 1 night. The monitors, based on standardized criteria set by the national level, should visit a
sample of these service points. Select 10% of the service points with the highest population. Prioritize
facilities that have:
 tOPV received just before the switch
 A history of non-compliance with immunization program policies
 DPT3 coverage <80%
 Management issues
 Other high risk characteristics (see Annex B)
15
This strategy will provide complete information on all cold chain stores from the national to the district level and
will provide information on many service points. These data will provide reasonable assurance of a successful
national switch within two weeks of the national switch date.
Results from the sampled service points will not be generalizable to all service points. Therefore, countries are
encouraged to ensure tOPV withdrawal from all service points through supportive supervision during the 2-3
months that follow the completion of independent monitoring.
Figure 1 below further illustrates how the purposive sampling should be conducted at the service point (health
facility) level.
16
2.4. Develop Micro-Plans
Using the list of stores that need to be monitored (all stores from the national to the district level) as well as the
list of service points that need to be visited based on the purposive sampling strategy; micro-plans should be
developed for each independent monitor (or monitoring team, if district or region is large). These micro-plans
should include the following:
 Schedule of stores to be visited over the monitoring period after the National Switch Day
 Mechanisms and procedures for reporting to supervisors
 Protocol for mop-up with stores if they cannot be visited on schedule
 Policies for what to do if tOPV is found
 Contact information for all stores to be visited
 Contact details of coordinators and supervisors (to be added when recruited).
Next, determine the modes of communication and data flow for each of the key participants. Consider the
following:
 Is there a mechanism already in place for information sharing?
 How frequently will information be shared between switch monitoring participants? What information?
Is the mechanism used to share information up the monitoring system (for example, from monitors to
supervisors or coordinators) as well as down the monitoring system (for example, from the National
Switch Validation Committee to the coordinators)?
 How will information be shared with the individuals implementing the switch?
 How quickly can information be passed from one participant to the next?
2.5. Develop Contingency Plans
Consider developing contingency plans for switch monitoring. For example:
 What will be done if not all of the cold chain stores and the selected service points are visited during the
monitoring period following the National Switch Day?
 What will be done if the number of service points that need visits increases because many of the initial
service point visits indicate that there have been problems with tOPV withdrawal?
Many problems can be dealt with during the mop-up monitoring period, but some problems may need to be
dealt with during the independent monitoring phase.
2.6. Recruit supervisors & monitors
It is recommended that one supervisor be recruited per region. The independent monitors should not be directly
involved with implementing the switch itself so that they can provide unbiased assessments of the
implementation of the switch. In-country partner organizations, such as non-governmental organizations,
universities, or professional groups, may be able to assist with providing people or other resources.
Main responsibilities for the supervisors:
 Provide the independent monitors with lists of sites to be assessed
 Provide training to independent monitors
17












Ensure that the independent monitors are able to travel to their assigned sites and move from one to
another as required.
Visit independent monitors in the field to check on the quality of work.
Observe performances of independent monitors and provide adequate feedback with corrective
measures as needed.
Be available for independent monitors to contact by phone at all times during monitoring period.
Arrange periodic debriefings with independent monitors, including at the end of the independent
monitors’ period of work
Collect the forms from independent monitors, review quality and reliability of data collection process,
and correct if required
Compile and analyse the data
Send summaries of findings to individuals coordinating the implementation of the switch in the area of
the supervisors’ responsibility.
Investigate to identify reasons for leftover tOPV and/or no introduction of bOPV and/or IPV.
Advise switch implementation staff on corrective actions in case tOPV is found at cold chain stores or
service points and/or IPV and bOPV is not available.
Provide the monitoring coordinator with any information needed to write the report for validation.
Facilitate the payment of the Independent monitors
Main responsibilities for the Independent Switch Monitors:
 Carry out the field monitoring activity
 Complete the monitoring forms provided
 Submit the completed forms daily to the supervisors
 Report to supervisor details about left over of tOPV and/or no introduction of bOPV and/or IPV
 Record any additional observation that may be helpful in identifying problems with the immunization
program
 Remove any tOPV found on visits to cold chain stores and service points unless the amount of tOPV
found is so large as to make this impractical. Hand over tOPV removed to supervisor or deliver to
disposal site as specified in the micro-plan.
Suggested criteria for selecting independent monitors
 Education:
o Completed at least a high school or secondary school level (BEPC)
o Have a good mastery of the official language of the country
o Be able to speak the local language and be able to operate in the local culture.
 Behaviour:
o Behave in line with the customs of the community visited
o Observe basic politeness rules: greetings, giving reasons for the visit
o Have the ability to work in a team and under pressure
o Know how to reformulate questions to make them more understandable without losing the
substance
 Experience:
o Some familiarity with logistics or the health care system
18
o

More experience will likely be needed for inspecting larger cold chain store facilities such as
national or regional cold chain stores
Cultural aspects:
o Be familiar with the country’s cultures and the languages and able to interview cold chain and
health facility staff
o Same ethnic and religious group as members of communities who may not cooperate with
members of different ethnic or religious groups
2.7. Train supervisors & monitors
The training should be conducted immediately prior to the switch in order to complete the entire monitoring
activity within the shortest time possible.
Trainers

The national independent monitoring coordinator with the assistance of WHO/UNICEF staff should do
an initial training of trainers.
 Following the national training of trainers, local training should be conducted by trained persons
including consultants where needed.
Organization of training
 A maximum of 30 trainees at one time is desirable. The method should focus on practical operational
issues with exercises and role-play to ensure the participation and involvement of the participants.
 Supervisors must attend the training and have additional sessions to train them on quality supervision
and to highlight their roles and responsibilities during the activity.
The monitors should be trained on:
 Roles and responsibilities
 Using micro-plans
 Verifying the absence of tOPV at selected facilities
 Removal of tOPV if any residual tOPV is found in facilities
 Completing recording forms to avoid data quality problems
 Communicating and reporting outcome of facility visits to supervisor
 If appropriate, confirming that there is a plan for tOPV disposal at each facility, if disposal has not been
completed
2.8. Pre-position supervisors & monitors
Supervisors and monitors must travel to their respective locations according to the plan and be ready to start
the independent monitoring in their designated sites on the National Switch Day.
Supplies required for independent monitors and supervisors:
 ID cards and reference letter;
 Phone credit;
 Data Collection Tools;
 Instruction sheets;
 Plastic bag and stickers in case tOPV is found;
 Notepad;
 Pens.
19
3. Validate
Plan
Prepare
Validate



Follow-Up
Monitors visit cold chain stores
Data reported and aggregated
Develop validation report
The validation process should include all tasks from the start of monitoring activity until the validation report is
developed, approved by the National Switch Validation Committee, sent to the ministry of health, and reported
to the WHO country office. The figure below shows a timeline with milestones, which can vary from country to
country with the goal of the validation process being completed within two weeks of the National Switch Day.
Figure 2: Example timeline to validate the switch
Begin
Monitoring
•Switch Day - Day 0
Complete Data
Collection
•Day 5
Compile Data
and Share
Report
•Day 11
Switch
Validated
•Day 14
3.1. Monitors visit cold chain stores and service delivery points
Beginning on the day after the National Switch Day, all independent monitors should systematically monitor
vaccine cold chain stores and service points as described:
National to District level stores: Independent monitors will visit 100% of the vaccine cold chain stores from the
national to the district level. If tOPV is found, the monitor will be expected to remove the vial(s) from the cold
chain and facilitate delivery to disposal site as described in the collection plan developed by the Switch Logistics
Working Group prior to the switch, document his/her findings, and report to the supervisor. If the amount of
tOPV found is large (would require another vehicle to transport), the monitor may not be able to remove all of
the tOPV and a follow-up visit may be needed to confirm that tOPV has been correctly withdrawn.
20
Service points: Independent monitors will monitor a sample of the facilities as described above. Finding tOPV in
the cold chain should prompt corrective action (removal of tOPV) and may trigger visits to additional sites for
verification of tOPV withdrawal.
In case one or more tOPV vials (opened or unopened) are found in the cold chain of the service points:
 The monitor will remove the vials from the cold chain and transport them to the nearest district or
region disposal site according to the disposal plan. The monitor may wait to transport the tOPV to the
disposal site until after he or she has completed his or her other monitoring activities.
 The supervisor will select an additional 5% of health facilities for monitors to visit.
If one or more tOPV vials containing vaccine (opened or unopened) are found in the additional 5% of visited
facilities, a sweep of all service points should be conducted for the whole district. Sweeping would mean an
intensified monitoring exercise with involvement of more district, regional and national staff, etc.
This strategy should continue until supervisors and coordinators feel all tOPV has been withdrawn from the cold
chain, even if this extends beyond the country validation date. If the visits to the service points will extend
beyond the two weeks following the National Switch Day, then they should fall under the usual National
Immunization Program’s supervision.
The graphic below further illustrates how the purposive sampling would be conducted at the service point
(health facility) level.
Figure 3: Site Visits and Corrective Action by Independent Monitors
Decision to Sweep a District or Region
21
•
Sweeping district: If tOPV is found after the second round of monitoring (i.e., additional 5% of sites),
the Monitoring Coordinator with the support of district immunization staff is responsible for overseeing
a SWEEP of entire district
•
Sweeping region: If 2 or more districts require sweeps, then involve regional and national staff to
conduct a broader assessment of the entire region
3.2. Data Reported and Aggregated



Independent monitors
o Hand over all data collection forms (see example in Annex C: Form 1-Sample Independent
Monitoring Data Collection Tool) to their supervisors on a daily basis or discuss findings over the
phone.
Coordinators/Supervisors
o Collect the data from the independent monitors and review the quality of information
o Compile the data collected into an aggregation tool (see example in Annex C: Form 2-Sample
National Switch Validation Data Aggregation Tool)
o Follow-up with monitors who have not turned in forms for their assigned facilities, according to
their micro-plans
o Send data to sub-national and national coordinator
o Aggregate results for National Switch Validation Committee to review
o Determine if any programmatic action is needed to remove tOPV if it is found in numerous cold
chain stores, and, if so, what action is needed
National Switch Validation Committee
o Will declare monitoring completed once it is satisfied that all national to district level cold chain
stores have withdrawn tOPV and that no further assessments or sweeps of service points are
needed under the guidelines described above.
o Will make the ultimate decision about whether or not the country can validate that there is no
longer tOPV being administered or present in the cold chain after the National Switch Day.
o May request the Switch Management Committee to gather additional information if they feel
they do not have enough data to validate the switch.
o Will report findings of the switch to national government, who should then send the report to
the WHO.
3.3. Develop validation report
After the National Switch Validation Committee has concluded whether or not the country can validate that
there is no longer tOPV being administered or present in the cold chain after the National Switch Day, the
committee should report its findings to the national government (see Annex C: Form 3-National Validation
Report). The national government should in turn report on the status of the switch, including a validation of the
switch, to the country and regional office of the World Health Organization.
22
4. Follow-Up
Plan
Prepare
Validate





Follow-Up
Additional monitoring of tOPV withdrawal
Correcting identified problems
Monitoring tOPV disposal
Future activities
Although the vast majority of the switch monitoring activities should take place during the 2 weeks immediately
following the National Switch Day, countries are encouraged to conduct mop-up activities through supportive
supervision in order to ensure that tOPV has been sufficiently removed from the cold chain and that the risk of
tOPV administration after the switch is low. The mop-up activities will also address problems with bOPV and IPV
introduction identified during the initial two weeks of monitoring. National Immunization Program staff can
carry out this mop-up activity during routine supervision. The mop-up should occur as soon as possible after the
switch and last no later than 2-3 months after the National Switch Day.
Countries may also consider developing a plan for monitoring tOPV disposal, which would be carried out over a
longer period than the 2 weeks of independent monitoring focused on tOPV withdrawal. Disposal of tOPV may
not be completed within the first two weeks following the National Switch Day, but disposal of tOPV and
monitoring of that disposal should be completed also within 2-3 months after the National Switch Day (see the
waste management section of the logistics guideline).
4.1. tOPV Withdrawal
While independent monitoring data collected during the first two weeks after the switch date are needed for
validation, mop-up activities through supportive supervision will further increase confidence in successful
withdrawal of tOPV. As the information on tOPV withdrawal collected from sampled service points will not be
generalizable to all service points, visits by National Immunization Program supervisors or district surveillance
officers to these sites is an important component of a successful switch.
National to District level cold chain stores: If the amount of tOPV found at a specific cold chain store was too
large to pick-up during the monitoring period, a follow-up visit may be needed to confirm that tOPV has been
correctly withdrawn. This follow-up visit may happen following the two weeks of independent monitoring but
should be prioritized and conducted as soon as possible.
23
Service points: Identification of tOPV remaining in the cold chain at sampled service points should prompt
monitoring visits to 5% additional service points, a sweep of service points in a district, or both. Some or all of
these additional visits or sweep activities may need to occur following the two weeks of independent monitoring
but needs to happen as soon as possible.
As the information on tOPV withdrawal collected from sampled service points will not be generalizable to all
service points, visits by National Immunization Program supervisors or district surveillance officers to service
points, particularly ones not visited by independent monitors, is an important component of a successful switch.
These supportive supervision visits should occur as soon as possible after the switch and no later than 2-3
months after the switch date.
4.2. Problems Identified during Monitoring
Problems with bOPV and IPV distribution identified through switch monitoring should have been reported to
National Immunization Programs’ staff, but may not have triggered further assessments by switch monitors or
immediately triggered sweeps of additional service points. All activity to follow-up on problems with bOPV and
IPV distribution and to assess the effectiveness of that follow-up will be handled through a National
Immunization Program’s existing methods of tracking vaccine distribution and coverage.
24
Annexes
Annex A: Monitoring tOPV Disposal
See section 3.4.4 of the Switch Implementation Guidelines for additional information on the WHO
recommendations for the disposal of tOPV”
In addition to monitoring tOPV withdrawal, bOPV introduction, and IPV distribution, countries may also want to
develop efficient mechanisms for assessing if tOPV is being promptly disposed of. Depending on a country’s
resources and preferences, some disposal activities may happen during the two weeks following the switch,
simultaneously with the independent monitoring of the switch, while others may occur more than two weeks
after the switch. Disposal of tOPV should occur as soon as possible, but no longer than 3 months after the
National Switch Day. Planners should refer to the waste management section of the Logistics Guideline to
develop a disposal monitoring plan.
As explained in the Logistics Guideline, prior to the switch it will be important:
 To conduct an inventory of all disposal equipment, recording if equipment is working and the volume of
material (vials, if possible) that the equipment can dispose of in 1 day.
 To develop a tOPV collection plan in sufficient detail that the movement of tOPV from collection to
disposal sites can be predicted and monitored. Individual plans may need to be developed at the
national, regional, and district levels of the health system and within each district.
The Logistics Guideline also describes options for collection and handing of tOPV, including:
 Supervisors pick up tOPV from cold chain stores and take to disposal site
 Staff from cold chain stores drop-off tOPV at a disposal site
 tOPV can be amassed from multiple health structures at district level and then can be moved to a
regional or national disposal site and disposed of
A collection/disposal plan should show the schedule for the planned movement and disposal of tOPV, which is
useful for planning supervisory visits. For example, all cold chain stores using a particular disposal site could
move their tOPV to that site on the same day or could move their tOPV to the disposal site on different days.
Due to the two week time limit on the operations of the independent monitors, they can help identify that tOPV
has been removed from a cold chain store or service point and confirm that plans are in place for disposal.
However, it is unlikely that the monitors will be able to confirm that tOPV has been disposed, where it has been
disposed of, and when. However, information collected in the independent monitors’ data collection tool, along
with information collected during supportive supervision visits, can be used to help track whether or not the
cold chain stores and service points have returned their tOPV and where it has been sent for disposal.
Monitoring tOPV disposal
1. Monitoring of tOPV disposal should focus on disposal of tOPV from national, regional, and district cold
chain stores because the volumes of tOPV stored at those facilities is potentially much greater than the
volume of tOPV stored at service points.
2. Cold chain store and service points should fill a short form or sticker listing the number of vials of tOPV
that are being sent for disposal
25
3. Preferably, the same information will be printed on the sticker that goes on the bags when withdrawing
the tOPV from the cold chain.
4. Disposal sites can use a form to check off when tOPV from a given cold chain store or a service point has
been received and disposed of (see Annex C for an example tOPV Disposal Form).
i. Alternative solutions, such as electronic data management systems, could also be used
to record vials of disposed tOPV
5. Supervisors should visit tOPV disposal sites to make sure that tOPV has been collected and promptly
disposed of. The records kept by the disposal site staff may be very helpful to the supervisors.
a. If the supervisor visits a disposal site and finds that it either has not received tOPV from all
expected stores or has not finished disposing of the tOPV it has received, he or she should
schedule a repeat trip. Multiple repeat trips may be needed before all expected tOPV has been
collected and disposed of.
6. Monitors record the amount of tOPV that a cold chain store or a service point sends for disposal and the
site of disposal using a data collection tool during visits to cold chain stores and service points (see
Annex C for an example Independent monitoring Data Collection Tool Error! Reference source not
found.)
7. Supervisors should ideally cross-check the amount of tOPV reported as having been sent for disposal by
cold chain stores with the amount of tOPV that disposal sites record as having been received and
destroyed to ensure that all vials were destroyed
8. Information collected on disposal of tOPV should be compiled and sent to the Switch Management
Committee.
26
Annex B: Categorizing Risk of tOPV Use
Suggested criteria for identifying High Risk districts/sub districts:
 AFP surveillance:
o Recent or on-going wild poliovirus circulation, either suspected or confirmed from AFP
surveillance or environmental surveillance.
o Clusters of AFP cases.
o Recent polio compatible cases
o Silent or underreporting areas
o Locality where the supervision is weak
 Immunization:
o Low routine immunization coverage with DTP3 or OPV3
o Under-performance in previous campaigns
o Discrepancies in numbers of children vaccinated between administrative data and coverage
surveys
o History of stock-outs
o Poor communications with or reporting to National Immunization Program or EPI
 Demographic and geographic characteristic:
o Densely populated areas
o Slums, displaced populations, refugee camps, crowded and highly populated urban area with
dense high-rise buildings, mobile communities including nomads and seasonal workers,
conservative communities, areas with administrative instability, management problems or
insecurity, etc.
o Border and hard to reach districts/areas
Risk of tOPV Stored and Used During the Switch
Level of Supply
Chain
Hypothetical scenario of tOPV storage and use
District and higher Storage of large stocks of tOPV in the cold chain at district level and
store levels
subsequent distribution to service points after the switch either
intentionally (for example, in response to stockout of bOPV) or
unintentionally (for example, because of confusion with bOPV)
Service
Short
Service points continue to use tOPV during the first month following
points
term
the switch.
Long
Service points store tOPV after the switch and use it months after
term
the switch, either accidentally or intentionally during a bOPV
stockout.
Use of scavenged If cold chain stores or service points withdraw tOPV from the cold
tOPV
chain but do not promptly dispose of it, that tOPV may be scavenged
and used for immunization or non-immunization purposes.
Likelihood of
occurrence
Low-Medium
Low
LowMedium
Low
Note: The forms included in this guide include the core indicators that are needed to validate the switch. Additional
indicators can be included if switch monitors are tasked with collecting information on other immunization activities.
27
Annex C: Example Forms
Form 1: Sample Independent Monitoring Data Collection Tool
Date of Monitoring: ____________________
Name of Monitor:
_____________________________
Level of cold chain: Primary: _____ Sub-National (Regional/Provincial): _______ Lowest distribution level (District): ______ Service Delivery Point (Fixed site): ________
Name of administrative level: ____________________________
Store Location or
Name
tOPV in
cold chain
(Yes = 1
No = 0)
tOPV
out of
cold
chain
without
label
“Do not
use”
(Yes = 1
No = 0)
A
B
C
bOPV in
cold
chain
(Yes = 1
No = 0)
IPV in
cold
chain
(Yes = 1
No = 0)
# vials
disposed or
pending
disposal at
time of
monitoring
# vials
destroyed
at service
point by
report
date
Disposal
method
(Multiple
codes okay)*
D
E
F
G
H
Corrective
actions**
(Multiple
codes okay)
Status
(ongoing
or
completed
Due
date, if
ongoing
I
J
K
1
2
3
4
5
6
7
8
9
10
TOTAL # stores
*Codes for disposal method: (1): Autoclave (2): Boiling (3): Incineration (4): Encapsulation (5): Burial (6): Burning (7): Other
**Codes for corrective action: (1): tOPV withdrawn (2): Onsite re-training (3): Officials at higher administrative level notified (4): Other (please specify)
28
Draft National Switch Data Aggregation Tool & Report_17 Feb 2016
Form 2: Sample NATIONAL Switch Validation Data Aggregation Tool
SECTION 1 – Vaccine Stores
Table 1: Aggregate INDEPENDENT MONITORING data for vaccine stores to lowest distribution level (excluding service points)
Vaccine Stores
Monitored
Indicators
tOPV out of
cold chain
without
label “Do
not use”
tOPV in cold
chain
Total #
stores
Administrative Level

A
B
bOPV
available
IPV
available
Disposal of tOPV
#
stores
%
#
stores
%*
#
stores
%
#
stores
%*
#
stores
%*
# vials
withdrawn
for disposal
by report
date
C
D
E
F
G
H
I
J
K
L
M
Disposal
method
(Multiple
codes
okay)**
N
Primary (National)
Sub-National (Regional
or Provincial)
Lowest distribution
level (District)
*denotes percent of monitored stores
**Codes for disposal method: (1): Autoclave (2): Boiling (3): Incineration (4): Encapsulation (5): Burial (6): Burning (7): Other
Table 2: Corrective action (to the lowest distribution level, excluding service points) If tOPV is found in the cold chain or outside it without labeling
Level of cold store
Location of cold store
Corrective actions implemented*** (Multiple codes okay)
Status (ongoing or
completed)
Due date, if ongoing
1
2
3
4
5
1.
2.
3.
4.
5.
6.
***Codes for corrective action:
(1): tOPV withdrawn (2): Onsite re-training (3): Officials at higher administrative level notified (4): Other (please specify)
29
Draft National Switch Data Aggregation Tool & Report_17 Feb 2016
SECTION 2 – Service Delivery Points (ie, health centers with fixed vaccination services):
Table 3: Aggregate INDEPENDENT MONITORING data for service delivery points by region (or district if desired by country)
Indicators 
# Monitored
tOPV out of
cold chain
without
label “Do
not use”
tOPV in cold
chain
Total #
Region

A
bOPV in cold
chain
IPV
in cold chain
Disposal of tOPV
#
points
%
#
points
%*
#
points
%
#
points
%*
#
points
%*
# vials
withdrawn
for disposal
by report
date
C
D
E
F
G
H
I
J
K
L
M
B
# vials
destroyed at
service point
by report
date
N
Region 1
Region 2
Region 3
*denotes percent of monitored stores
Table 4: If tOPV sweep is required in district, list corrective action:
District
Number of service
points swept
Corrective actions implemented**
Status (ongoing or
completed)
Due date, if ongoing
B
B
C
D
E
1.
2.
3.
4.
5.
6.
7.
8.
**Codes for corrective action: (1): tOPV collected from all facilities (2): Onsite retraining at sites with tOPV in cold-chain or unlabeled for destruction (3): Officials at higher administrative
level notified (4): Other (please specify)
30
Form 3: NATIONAL VALIDATION REPORT: Switch from tOPV to bOPV
Action: Complete form and submit to WHO Country Office
Responsible authority: Ministry of Health supported by National Switch Validation Committee
Reporting deadline: 2 weeks after National switch date or latest 15 May 2016
Country:
Date of Switch:
Table 1: For each indicator identified below, check Yes or No. Please insert comments as appropriate:
Indicators
A
B
Yes
No
Comments
Switch has been validated* by country
If Yes, report date;
If No, report additional corrective action
needed & expected date of validation**
C
Independent monitoring used for Switch
D
Switch will continue to be monitored through
routine EPI reporting
E
Switch Validation
validation data
Committee
reviewed
*Defined as 0% detection of tOPV in cold chain or outside without appropriate label
**Codes for corrective action (multiple may be listed): (1) Region sweep (2) District(s) sweep (3) Re -training (4) Request for
additional data (5) Other (please specify)
Table 2: For each cold chain level, report aggregate INDEPENDENT national monitoring data on tOPV and bOPV after National
Switch Day.
Indicators 
Site monitoring
Administrative Level

Total
# Monitored
%
A
B
C
D
Primary (National)
Sub-National (Regional or
Provincial)
Lowest distribution level
(District)
Service
delivery
point
(fixed vaccination services)
***If IPV has been introduced
*Denotes percent of monitored sites
National Switch Validation Committee Chairperson
or designee (Name, signature, & date)
Minister of Health or government designee (Name,
signature, & date)
31
tOPV in cold
chain or
outside
without
proper label
bOPV
at site
IPV
at
site***
%*
%*
%*
E
F
G
Excess # tOPV
vials disposed
or needing
disposal (at
time of report)
H
Instruction Sheet: National Switch Data Aggregation Form & Validation Report
“Validation” of the Switch: Two forms are used to aggregate and report independent monitoring data collected within 2 weeks of the National Switch
date and validation of the switch. The primary data indicators for validating the switch are 0% detection of tOPV in the cold chain or outside cold chain
without appropriate label (for example, “Do not use/Destroy”) at any level of monitored stores (as recommended in the WHO Monitoring Guidelines).
If problems with the switch are detected, corrective action should be taken by the government.
In addition, the monitoring and validation process is also an opportunity to ensure bOPV and IPV availability (if introduced). It is important to note that
disposal is not expected to be complete before validation but receiving available data at the time of report is still useful.



Form 1: Independent Monitoring Data Collection Tool: to be completed by independent monitors and submitted to reporting official at the
administrative level on a daily basis
Form 2: National Switch Data Aggregation Tool: to be completed by National authorities after independent monitoring at subnational levels.
Data form should be submitted for review by the National Switch Validation Committee (NSVC) or National Certification Committee (NCC) or
other designated Committee
Form 3: National Switch Validation Report: After review by the NVSC or NCC of Form 2, this form should be completed by the National
authorities and signed by the designated government authority. Government should submit form to WHO Country Office.
Responsible Authority: National Government
Action: Complete the two attached forms within 2 weeks of the National Switch Date, starting with Forms 1 and 2 which will inform Form 3.
Forms 1 & 2: Independent
Monitoring Data Collection &
National Aggregation Tool
Purpose: National EPI Program to aggregate
data on Switch monitoring indicators submitted
by subnational levels. Note: Subnational levels
Form 3: National Switch
Validation Report
Purpose: To summarize findings of Switch
Validation review by NSVC/NCC and MOH
may modify the form for their own use.
32
Action: Submit aggregation forms to
NSVC/NCC within 1-2 weeks of the National
Action: Complete after NSCV/NCC review,
obtain relevant signatures, and submit to WHO
Country Office within 2 weeks of National Switch
Draft National Switch Data Aggregation Tool & Report_29 Jan 2016
Instructions for FORM 1 – Independent Monitoring Data Collection Tool: NOTE: These forms are intended
to be used by the Independent Monitors. Complete separate form for each administrative level (primary,
subnational, district, and service delivery points with fixed vaccination services).
Complete a separate table for each administrative level being monitored. List:
-Date of monitoring
-Name of monitor
-Select level of cold chain: Primary (National; Sub-National (Regional or Provincial); Lowest distribution level (District); or Service delivery point (Health post
with fixed vaccination services)
-List name or location of the administrative level: (e.g., State Name, District Name)











Column A: Location or Name of the cold store or service delivery point
Column B: Is tOPV found in the cold chain? Yes = 1; No = 0
Column C: Is with tOPV outside cold chain, not properly packed in plastic bag or container labeled (e.g., “Do not use/Destroy”)? Yes = 1; No = 0
Column D: Is bOPV found in the cold chain? Yes = 1; No = 0
Column E: Is IPV found in the cold chain? Yes = 1; No = 0
Column F: Total number of tOPV vials disposed or pending disposal at that level, by monitoring date. For service deliver points, this may be the number of tOPV
vials returned (or planned) for destruction either to district cold chain store or to off-site waste management facility. The best estimate for this is likely the excess
tOPV withdrawn based on the stock ledger. NOTE: To avoid double counting, do not include tOPV vials sent in to this level after the Switch Date from other levels
for disposal.
Column G: Number of tOPV vials that were destroyed on-site by report date, if any.
Column H: Enter methods used for tOPV disposal using the codes provided, multiple methods can be recorded.
Column I: List the corrective actions implemented**, in any, using provided codes.
Column J: List the status of the corrective action as ongoing or completed
Column K: If corrective action is ongoing, list anticipated due date of completion.
Tally the totals for Columns B-G.
Submit these forms on a daily basis to the reporting official for the administrative level being monitored.
** Note: According to the WHO Monitoring Guidelines:
33
Draft National Switch Data Aggregation Tool & Report_29 Jan 2016
1) Cold stores from National to the Lowest Distribution Level (District): 100% of the cold stores should be independently monitored. Corrective action should be
taken for any tOPV in the cold chain or not properly packed in plastic bag or container labeled (e.g., “Do not use/Destroy”). tOPV should be withdrawn from
the cold chain and reported to the administrative official.
2) Service Delivery Points: Use the risk-based purposive sampling to monitor selected service delivery points or health posts with fixed vaccination services. If
tOPV is found in the cold chain of the initial 10% of the selected monitoring sites and again in the subsequently selected 5% of the sites, then sweep (tOPV
monitoring) of all service delivery points in the district is required in coordination with the administrative official for the district.
34
Draft National Switch Data Aggregation Tool & Report_29 Jan 2016
Instructions for FORM 2 -- National Switch Aggregation Tool: NOTE: These forms are intended to be used by the
NATIONAL AUTHORITIES, using data from independent monitoring (Form 1), and may be modified for each
administrative level (subnational and district) as deemed appropriate
Step 1: Complete Section 1, Table 1: Aggregate INDEPENDENT MONITORING data for vaccine stores to lowest distribution level (excluding service
points)













Column A: Type of vaccine store, if the country have more than 3 levels of vaccine store then add more lines
Column B: Total number of stores by level in the country
Column C: Number of stores independently monitored
Column D: Percent of stores independently monitored: (C/B)*100
Column E: Number of stores with tOPV in cold chain
Column F: Of those monitored, % of stores with tOPV in cold chain: (E/B)*100
Column G: Number of stores with tOPV outside cold chain, not properly packed in plastic bag or container labeled (eg, “Do not use/Destroy”)
Column H: Of those monitored, % of stores with tOPV outside cold chain not packed without label: (G/B)*100
Column I: Number of stores with bOPV in cold chain among those monitored
Column J: Of those monitored, percent of stores with bOPV: (I/B)*100
Column K: Number of stores with IPV in cold chain (if IPV has been introduced in the country)
Column L: Of those monitored, percent of stores with IPV among those monitored: (K/B)*100
Column M: Total number of tOPV vials disposed or pending disposal at that level, by report date. The best estimate for this is likely the excess tOPV withdrawn
based on the stock ledger. NOTE: To avoid double counting, do not include tOPV vials sent in to this level after the Switch Date from other levels for disposal.
 Column N: List all methods of disposal used by this level for tOPV destruction using provided codes. Multiple codes may be selected. If other, please specify.
Step 2: Complete Section 1, Table 2 -- Corrective Action: For corrective action taken at stores in each level, list the level of cold chain, location of the cold chain
and the corrective actions implemented using provided codes. List the status of the corrective action (ongoing or completed) and if ongoing, due date of completion.
Step 3: Complete Section 2, Table 3 Aggregate INDEPENDENT MONITORING (WHO Monitoring Guidelines) and DISPOSAL data for service delivery
facilities with fixed vaccination services, by Region












Column A: Region or Province name (if desired by country, these may be aggregated by District)
Column B: Total number of total Service delivery facilities in country
Column C: Number of service delivery facilities that were independently monitored
Column D: Percent of independently monitored service delivery facilities: (C/B)*100
Column E: Number of sites with tOPV in cold chain
Column F: Of those monitored, percent with tOPV in cold chain: (E/B)*100
Column G: Number of sites with tOPV outside cold chain, without proper label
Column H: Of those monitored, percent with tOPV outside cold chain without proper label: (G/B)*100
Column I: Number of sites with bOPV in cold chain
Column J: Of those monitored, percent with bOPV in cold chain: (I/B)*100
Column K: Number of sites with IPV in cold chain (if IPV has been introduced in country)
Column L: Of those monitored, percent with IPV in cold chain: (K/B)*100
35
Draft National Switch Data Aggregation Tool & Report_29 Jan 2016


Column M: Number of tOPV vials returned (or planned) for destruction either to district cold chain store or to off-site waste management facility. Best estimate for
this may be excess tOPV based on stock ledger
Column N: Number of tOPV vials that were destroyed on-site by the service delivery facility by report date
Step 4: Complete Section 2, Table 4: For corrective action taken at the service delivery level, list all districts that required sweep of tOPV according to the
independent monitoring guidelines (e.g., tOPV was found in the initial 10% of the selected monitoring sites and again in the subsequently selected 5% of the sites). For
each sweep, list the district, number of service points swept, and corrective actions implemented. Note: the form may be modified at district level to list the individual
service points that had tOPV in the cold chain.
Instructions for FORM 3 – National Switch Validation Report



Responsible Authority: After review by NSVC/NCC of Form 2, Ministry of Health will complete this form and obtain the appropriate
signatures from the Government designee and Chairperson of the NSCV/NCC
Outcome of this report: is to Validate that tOPV is appropriately removed from the cold chain in the National EPI Program; secondary
objective is to ensure bOPV is available at all levels.
Reporting deadline: is within 2 weeks of the National Switch Date or latest 15 May 2016
Step 1: Complete Table 1: Check ‘Yes’ or ‘No’ for each indicator for the National Validation of the Switch. Insert comments as appropriate.
 Row A: Select if Switch has been validated by country after review by the NSVC/NCC or other designated Committee. The primary data
indicators for validating the switch includes 0% detection of tOPV in the cold chain or outside cold chain without appropriate label (for
example, “Do not use/Destroy”) at any level (as recommended in the WHO Monitoring Guidelines) with the locally implemented corrective
action if necessary.
 Row B. If switch is validated, provide date of validation; if not validated, list planned corrective actions using provided codes and expected
date of validation by country. Examples of corrective actions may include additional sweep of district(s) or region(s), or request for
collection of additional data.
 Row C: State if independent monitoring was used to validate the switch.
 Row D: State whether the switch indicators will continue to be monitored through ongoing routine EPI reporting and supportive supervision.
Examples may include: adding switch indicators to the monthly reports from health facilities to districts, and from districts to the next
administrative level, as well as ensuring that supervisors and managers are monitoring for tOPV absence and availability of bOPV and IPV
when assessing health facility’s information system.
 Row E: Select if the NSVC, NCC, or other designated committee reviewed switch validation data
Step 2: Complete Table 2: Summarize the aggregated national data on tOPV using Form 1 (National Switch Data Aggregation Tool) and accompanying
instructions.

Column A: Administrative level for vaccine stores and service delivery points
36
Draft National Switch Data Aggregation Tool & Report_29 Jan 2016







Column B: Total number of sites (vaccine stores and service delivery points) at each administrative level in country
Column C: Number of sites (vaccine stores and service delivery points) that were independently monitored
Column D: Percent of independently monitored sites: (C/B)*100
Column E: Of those monitored, percent of sites with tOPV in cold chain or without proper label: (E/C)*100
Column F: Of those monitored, percent of sites with bOPV: (F/C)*100
Column G: Of those monitored, percent of sites with IPV: (G/C)*100
Column H: Of those sites monitored, total number of vials of tOPV disposed or needing to be disposed
Step 3: Obtain signatures from Chairperson of the NSVC/NCC (or designated committee) and the MOH designee who affirms National validation of the
switch
Step 4: Submit form electronically to the WHO Country Office.
[Print these instructions on the backside of each accompanying form]
tOPV Disposal Form – Supervisors
(Monitor fills out)
Disposal Site Name:
Region:
District:
Disposal
Site
Name
Level of
Disposal
Site*
Region
Supervisor name:
District
Date
of Visit
tOPV
Disposal
Completed?
Supervisor phone number:
# of tOPV
vials
disposed
of to date
Date
of Visit
tOPV
Disposal
Completed?
# of tOPV
vials
disposed
of to date
Date
of Visit
tOPV
Disposal
Completed?
# of tOPV
vials
disposed
of to date
1
2
3
4
5
6
7
8
9
10
11
12
13
14
37
Draft National Switch Data Aggregation Tool & Report_29 Jan 2016
15
16
17
18
19
Total
*Write one of the following types of facilities: National store, Regional store, District store, Service Point (SP).
Form may be modified as needed to suit needs of country.
38